Developing and producing high-quality psilocybin products for research and drug development
Contributing to research to explore psilocybin’s potential for treating a variety of mental health conditions
Almost 1 billion people worldwide suffer from a mental or substance-use disorder.
Psychedelic therapies are delivering significant results. JMCC will offer three bulk products:
To date, we have completed multiple Health Canada approved psilocybin imports.